Analysts await Mesoblast Limited (NASDAQ:MESO) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

At the moment 5 analysts are watching Mesoblast Limited (NASDAQ:MESO), 1 rate it “Buy”, 2 “Outperform”, 2 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Dec-16, 4 analysts have a mean sales target of 5.53 million. For the quarter ending Mar-16, 3 analysts have a mean sales target of 14.02 million whilst for the year ending Jun-16, 4 analysts have a mean target of 36.73 million.

In terms of earnings per share, 2 analysts have a -0.22 EPS mean target for the quarter ending Dec-16, for the quarter ending Mar-16, 2 analysts have a -0.28 EPS mean target and for the quarter ending Mar-16 there are 4 estimates of -0.85 EPS.

Total shares held by institutions as of the most recent company filings are with a reported bought and sold. These holdings make up of the company’s outstanding shares.

The stock decreased 3.10% or $0.24 during the last trading session.